• No results found

University of Groningen Pemphigoid diseases: Insights in the nonbullous variant and disease management Lamberts, Aniek

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Pemphigoid diseases: Insights in the nonbullous variant and disease management Lamberts, Aniek"

Copied!
8
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Pemphigoid diseases: Insights in the nonbullous variant and disease management Lamberts, Aniek

DOI:

10.33612/diss.132159641

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date: 2020

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Lamberts, A. (2020). Pemphigoid diseases: Insights in the nonbullous variant and disease management. University of Groningen. https://doi.org/10.33612/diss.132159641

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

Pemphigoid diseases: insights in the

nonbullous variant and disease management

(3)

ISBN: 978-94-034-2431-6

ISBN: 978-94-034-2430-9 (e-book)

©Copyright M.A. Lamberts 2020, the Netherlands

All rights reserved. No part of this thesis may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying,

recording, or by any information storage or retrieval system, without written permission of the author. The copyright of previously published chapters of this thesis remains with the publisher or journal.

Financial support for the publication of this thesis was provided by:

nanoString, Eurocept, Rijksuniversiteit Groningen, Studiefonds Dermatologie, Universitair Medisch Centrum Groningen.

Cover design: Martijn O. Wolf – MOTTOW – mottow.nl Interior design: Aniek Lamberts

(4)

Pemphigoid diseases: insights in the

nonbullous variant and disease management

Proefschrift

ter verkrijging van de graad van doctor aan de Rijksuniversiteit Groningen

op gezag van de

rector magnificus prof. dr. C. Wijmenga en volgens besluit van het College voor Promoties.

De openbare verdediging zal plaatsvinden op dinsdag 22 september 2020 om 11.00 uur

door

Marlou Aniek Lamberts geboren op 17 juli 1990

(5)

Promotores Dr. B. Horváth Prof. dr. M.F. Jonkman† Copromotor Dr. H.H. Pas Reading committee Prof. dr. P. Heeringa Prof. dr. M.A. de Rie Prof. dr. R. Ludwig

(6)

Paranimfen Lisette Prens Angelique Rondags

(7)

Table of contents

Chapter 1 Introduction in pemphigoid diseases 9

PART 1

Nonbullous pemphigoid: disease characteristics

and immunological aspects

Chapter 2 Significantly higher prevalence of circulating bullous 35 pemphigoid-specific IgG autoantibodies in elderly

patients with a nonbullous skin disorder

Chapter 3 Nonbullous pemphigoid: a systematic review 43

Chapter 4 Nonbullous pemphigoid: insights in clinical and 61 diagnostic findings, treatment response and prognosis

Chapter 4A Reply to: “Pruritus with pemphigoid autoantibodies 81 is the tip of an iceberg”

Chapter 5 Prevalence of pemphigoid as a potentially unrecognized 85 cause of pruritus in nursing home residents

Chapter 6 IgE autoantibodies in serum and skin of nonbullous and 93 bullous pemphigoid patients

Chapter 7 Gene expression profile of lesional skin in bullous and 111 nonbullous pemphigoid: an explorative pilot study

(8)

PART 2

Management of pemphigoid diseases

Chapter 8 Unmet needs in pemphigoid diseases: an international 133

survey amongst patients, clinicians and researchers Chapter 9 Effectiveness and safety of rituximab in recalcitrant 147

pemphigoid diseases Chapter 10 Determining the incidence of pneumocystis pneumonia 171

in patients with autoimmune blistering diseases not receiving routine prophylaxis Chapter 11 Discussion and future perspectives 185

Chapter 12 Summary 209

Chapter 13 Samenvatting 217

Appendices Dankwoord 226

List of publications 228

Referenties

GERELATEERDE DOCUMENTEN

R, range; AIBD, autoimmune blistering diseases; * Ranking score was calculated by awarding three points for every time an unmet needs was ranked highest, two points if ranked second

Patients with bullous pemphigoid (n=8), mucous membrane pemphigoid (n=14), epidermolysis bullosa acquisita (n=5) and linear IgA disease (n=1) were included.. Eight patients

Role of primary prophylaxis for Pneumocystis pneumonia in patients treated with systemic corticosteroids or other immunosuppressive agents for immune- mediated dermatologic

was recommended for monitoring disease activity in confirmed pemphigoid patients. Their findings were translated into a 2-out-of-3 rule for the diagnosis of pemphigoid,

Pemphigoid diseases: Insights in the nonbullous variant and disease management Lamberts,

Daarnaast droegen pemfigoïd patiënten aan dat er een grote noodzaak is voor meer ziekte bewustzijn onder clinici, om vertragingen en het stellen van een foutieve diagnose

Pemphigoid diseases: Insights in the nonbullous variant and disease management Lamberts,

The indications for pneumocystis pneumonia prophylaxis are not clearly defined, but standard prophylaxis does not seem required for all pemphigoid patients. Somewhere,